American Vanguard (AVD)
(Delayed Data from NYSE)
$8.85 USD
-0.35 (-3.80%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $8.83 -0.02 (-0.23%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth F Momentum F VGM
Brokerage Reports
American Vanguard Corporation [AVD]
Reports for Purchase
Showing records 141 - 160 ( 196 total )
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Travels with management: retail inventories normal, focus on building growth
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Model flattening, modest near-term growth, substantial long-term, STRONG BUY
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Earlier this month met with management at annual meeting, growth strategy emerging
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
1Q met revised expectations, waiting for customer pull on CSI, cutworm implications?
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Updating model for acquisition of European assets announced earlier this week
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
4Q below us, gradual recovery likely, survey of dealers generally positive
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
January Effect Ideas
Provider: Feltl & Company
Company: American Vanguard Corporation
Industry: Chemical - Specialty
3Q inline, we think bottom is likely in, results should start to gradually rebuild
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
2Q inline with revised guidance, lowering estimates but more confident in recovery
Provider: FELTL & COMPANY
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Lowering estimates on weak 2Q, looking for bottom, reasons to be optimistic?
Provider: FELTL & COMPANY
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Lowering estimates on weak 2Q, looking for bottom, reasons to be optimistic?
Provider: FELTL & COMPANY
Analyst: RYSTROM B